<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35205026</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2079-7737</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>19</Day></PubDate></JournalIssue><Title>Biology</Title><ISOAbbreviation>Biology (Basel)</ISOAbbreviation></Journal><ArticleTitle>Redox Homeostasis and Immune Alterations in Coronavirus Disease-19.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">159</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biology11020159</ELocationID><Abstract><AbstractText>The global Coronavirus Disease 2019 (COVID-19) pandemic is characterized by a wide variety of clinical features, from no or moderate symptoms to severe illness. COVID-19 is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that first affects the respiratory tract. Other than being limited to lungs, SARS-CoV-2 may lead to a multisystem disease that can even be durable (long COVID). The clinical spectrum of COVID-19 depends on variability in the immune regulation. Indeed, disease progression is consequent to failure in the immune regulation, characterized by an intensification of the pro-inflammatory response. Disturbance of systemic and organ-related redox balance may be a further mechanism underlying variability in COVID-19 severity. Other than being determinant for SARS-CoV-2 entry and fusion to the host cell, reactive species and redox signaling are deeply involved in the immune response. This review sums up the present knowledge on the role of redox balance in the regulation of susceptibility to SARS-CoV-2 infection and related immune response, debating the effectiveness of antioxidant compounds in the management of COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bellanti</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-8196-7373</Identifier><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, University of Foggia, Viale Pinto 1, 71122 Foggia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lo Buglio</LastName><ForeName>Aurelio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1569-3658</Identifier><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, University of Foggia, Viale Pinto 1, 71122 Foggia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vendemiale</LastName><ForeName>Gianluigi</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, University of Foggia, Viale Pinto 1, 71122 Foggia, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biology (Basel)</MedlineTA><NlmUniqueID>101587988</NlmUniqueID><ISSNLinking>2079-7737</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">immune response</Keyword><Keyword MajorTopicYN="N">redox balance</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>25</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35205026</ArticleId><ArticleId IdType="pmc">PMC8869285</ArticleId><ArticleId IdType="doi">10.3390/biology11020159</ArticleId><ArticleId IdType="pii">biology11020159</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization WHO  Director-General&#x2019;s Opening Remarks at the Media Briefing On COVID-19. 2020.  [(accessed on 1 December 2021)].  Gen Open Remarks Media Brief COVID-19. Available online:  https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-mediabriefing-on-covid-19%2D%2D-11-march-2020.</Citation></Reference><Reference><Citation>Worldometer COVID-19 Coronavirus Pandemic  Gen. Open Remarks Media Brief COVID-19. 2021.  [(accessed on 1 December 2021)].  Available online:  https://www.worldometers.info/coronavirus/</Citation></Reference><Reference><Citation>Andersen K.G., Rambaut A., Lipkin W.I., Holmes E.C., Garry R.F. The proximal origin of SARS-CoV-2. Nat. Med. 2020;26:450&#x2013;452. doi: 10.1038/s41591-020-0820-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0820-9</ArticleId><ArticleId IdType="pmc">PMC7095063</ArticleId><ArticleId IdType="pubmed">32284615</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A., Bernabei R., Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z., Peng F., Xu B., Zhao J., Liu H., Peng J., Li Q., Jiang C., Zhou Y., Liu S., et al. Risk factors of critical &amp; mortal COVID-19 cases: A systematic literature review and meta-analysis. J. Infect. 2020;81:e16&#x2013;e25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7177098</ArticleId><ArticleId IdType="pubmed">32335169</ArticleId></ArticleIdList></Reference><Reference><Citation>Liguoro I., Pilotto C., Bonanni M., Ferrari M.E., Pusiol A., Nocerino A., Vidal E., Cogo P. SARS-CoV-2 infection in children and newborns: A systematic review. Eur. J. Pediatr. 2020;179:1029&#x2013;1046. doi: 10.1007/s00431-020-03684-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-020-03684-7</ArticleId><ArticleId IdType="pmc">PMC7234446</ArticleId><ArticleId IdType="pubmed">32424745</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajaj V., Gadi N., Spihlman A.P., Wu S.C., Choi C.H., Moulton V.R. Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections? Front. Physiol. 2020;11:571416. doi: 10.3389/fphys.2020.571416.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.571416</ArticleId><ArticleId IdType="pmc">PMC7835928</ArticleId><ArticleId IdType="pubmed">33510644</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw A.C., Goldstein D.R., Montgomery R.R. Age-dependent dysregulation of innate immunity. Nat Rev. Immunol. 2013;13:875&#x2013;887. doi: 10.1038/nri3547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3547</ArticleId><ArticleId IdType="pmc">PMC4096436</ArticleId><ArticleId IdType="pubmed">24157572</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulop T., Larbi A., Dupuis G., Le P.A., Frost E.H., Cohen A.A., Witkowski J.M., Franceschi C. Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes? Front. Immunol. 2017;8:1960. doi: 10.3389/fimmu.2017.01960.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01960</ArticleId><ArticleId IdType="pmc">PMC5767595</ArticleId><ArticleId IdType="pubmed">29375577</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Fu B., Zheng X., Wang D., Zhao C., Qi Y., Sun R., Tian Z., Xu X., Wei H. Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients. Natl. Sci. Rev. 2020;7:998&#x2013;1002. doi: 10.1093/nsr/nwaa041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nsr/nwaa041</ArticleId><ArticleId IdType="pmc">PMC7108005</ArticleId><ArticleId IdType="pubmed">34676125</ArticleId></ArticleIdList></Reference><Reference><Citation>Gostner J.M., Becker K., Fuchs D., Sucher R. Redox regulation of the immune response. Redox Rep. 2013;18:88&#x2013;94. doi: 10.1179/1351000213Y.0000000044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/1351000213Y.0000000044</ArticleId><ArticleId IdType="pmc">PMC6837572</ArticleId><ArticleId IdType="pubmed">23601165</ArticleId></ArticleIdList></Reference><Reference><Citation>Muri J., Kopf M. Redox regulation of immunometabolism. Nat. Rev. Immunol. 2021;21:363&#x2013;381. doi: 10.1038/s41577-020-00478-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-00478-8</ArticleId><ArticleId IdType="pubmed">33340021</ArticleId></ArticleIdList></Reference><Reference><Citation>Reshi M.L., Su Y.C., Hong J.R. RNA Viruses: ROS-Mediated Cell Death. Int. J. Cell Biol. 2014;2014:467452. doi: 10.1155/2014/467452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/467452</ArticleId><ArticleId IdType="pmc">PMC4034720</ArticleId><ArticleId IdType="pubmed">24899897</ArticleId></ArticleIdList></Reference><Reference><Citation>Sies H., Berndt C., Jones D.P. Oxidative Stress. Annu. Rev. Biochem. 2017;86:715&#x2013;748. doi: 10.1146/annurev-biochem-061516-045037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biochem-061516-045037</ArticleId><ArticleId IdType="pubmed">28441057</ArticleId></ArticleIdList></Reference><Reference><Citation>Mates J.M., Perez-Gomez C., De Castro I.N. Antioxidant enzymes and human diseases. Clin. Biochem. 1999;32:595&#x2013;603. doi: 10.1016/S0009-9120(99)00075-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0009-9120(99)00075-2</ArticleId><ArticleId IdType="pubmed">10638941</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigarella C.L., Liang R., Ghaffari S. Stem cells and the impact of ROS signaling. Development. 2014;141:4206&#x2013;4218. doi: 10.1242/dev.107086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.107086</ArticleId><ArticleId IdType="pmc">PMC4302918</ArticleId><ArticleId IdType="pubmed">25371358</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohal R.S., Svensson I., Brunk U.T. Hydrogen peroxide production by liver mitochondria in different species. Mech. Ageing Dev. 1990;53:209&#x2013;215. doi: 10.1016/0047-6374(90)90039-I.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0047-6374(90)90039-I</ArticleId><ArticleId IdType="pubmed">2115947</ArticleId></ArticleIdList></Reference><Reference><Citation>St-Pierre J., Buckingham J.A., Roebuck S.J., Brand M.D. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J. Biol. Chem. 2002;277:44784&#x2013;44790. doi: 10.1074/jbc.M207217200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M207217200</ArticleId><ArticleId IdType="pubmed">12237311</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabharwal S.S., Schumacker P.T. Mitochondrial ROS in cancer: Initiators, amplifiers or an Achilles&#x2019; heel? Nat. Rev. Cancer. 2014;14:709&#x2013;721. doi: 10.1038/nrc3803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc3803</ArticleId><ArticleId IdType="pmc">PMC4657553</ArticleId><ArticleId IdType="pubmed">25342630</ArticleId></ArticleIdList></Reference><Reference><Citation>Ott M., Gogvadze V., Orrenius S., Zhivotovsky B. Mitochondria, oxidative stress and cell death. Apoptosis. 2007;12:913&#x2013;922. doi: 10.1007/s10495-007-0756-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10495-007-0756-2</ArticleId><ArticleId IdType="pubmed">17453160</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H.C., Ma T.H., Tjong W.Y., Stern A., Chiu D.T. G6PD deficiency, redox homeostasis, and viral infections: Implications for SARS-CoV-2 (COVID-19) Free Radic. Res. 2021;55:364&#x2013;374. doi: 10.1080/10715762.2020.1866757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10715762.2020.1866757</ArticleId><ArticleId IdType="pmc">PMC7799378</ArticleId><ArticleId IdType="pubmed">33401987</ArticleId></ArticleIdList></Reference><Reference><Citation>Laloi C., Apel K., Danon A. Reactive oxygen signalling: The latest news. Curr. Opin. Plant Biol. 2004;7:323&#x2013;328. doi: 10.1016/j.pbi.2004.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pbi.2004.03.005</ArticleId><ArticleId IdType="pubmed">15134754</ArticleId></ArticleIdList></Reference><Reference><Citation>Serviddio G., Bellanti F., Vendemiale G. Free radical biology for medicine: Learning from nonalcoholic fatty liver disease. Free Radic. Biol. Med. 2013;65:952&#x2013;968. doi: 10.1016/j.freeradbiomed.2013.08.174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2013.08.174</ArticleId><ArticleId IdType="pubmed">23994574</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang R., Ghaffari S. Stem cells, redox signaling, and stem cell aging. Antioxid. Redox Signal. 2014;20:1902&#x2013;1916. doi: 10.1089/ars.2013.5300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2013.5300</ArticleId><ArticleId IdType="pmc">PMC3967383</ArticleId><ArticleId IdType="pubmed">24383555</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmstrom K.M., Finkel T. Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat. Rev. Mol. Cell Biol. 2014;15:411&#x2013;421. doi: 10.1038/nrm3801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3801</ArticleId><ArticleId IdType="pubmed">24854789</ArticleId></ArticleIdList></Reference><Reference><Citation>Orrenius S., Zhivotovsky B., Nicotera P. Regulation of cell death: The calcium-apoptosis link. Nat. Rev. Mol. Cell Biol. 2003;4:552&#x2013;565. doi: 10.1038/nrm1150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm1150</ArticleId><ArticleId IdType="pubmed">12838338</ArticleId></ArticleIdList></Reference><Reference><Citation>Patron M., Raffaello A., Granatiero V., Tosatto A., Merli G., De S.D., Wright L., Pallafacchina G., Terrin A., Mammucari C., et al. The mitochondrial calcium uniporter (MCU): Molecular identity and physiological roles. J. Biol. Chem. 2013;288:10750&#x2013;10758. doi: 10.1074/jbc.R112.420752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R112.420752</ArticleId><ArticleId IdType="pmc">PMC3624455</ArticleId><ArticleId IdType="pubmed">23400777</ArticleId></ArticleIdList></Reference><Reference><Citation>Motohashi H., Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med. 2004;10:549&#x2013;557. doi: 10.1016/j.molmed.2004.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2004.09.003</ArticleId><ArticleId IdType="pubmed">15519281</ArticleId></ArticleIdList></Reference><Reference><Citation>Sablina A.A., Budanov A.V., Ilyinskaya G.V., Agapova L.S., Kravchenko J.E., Chumakov P.M. The antioxidant function of the p53 tumor suppressor. Nat. Med. 2005;11:1306&#x2013;1313. doi: 10.1038/nm1320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1320</ArticleId><ArticleId IdType="pmc">PMC2637821</ArticleId><ArticleId IdType="pubmed">16286925</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H., Colavitti R., Rovira I.I., Finkel T. Redox-dependent transcriptional regulation. Circ. Res. 2005;97:967&#x2013;974. doi: 10.1161/01.RES.0000188210.72062.10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.0000188210.72062.10</ArticleId><ArticleId IdType="pubmed">16284189</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomko R.J., Jr., Bansal P., Lazo J.S. Airing out an antioxidant role for the tumor suppressor p53. Mol. Interv. 2006;6:23&#x2013;25. doi: 10.1124/mi.6.1.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mi.6.1.5</ArticleId><ArticleId IdType="pubmed">16507747</ArticleId></ArticleIdList></Reference><Reference><Citation>Funato Y., Michiue T., Asashima M., Miki H. The thioredoxin-related redox-regulating protein nucleoredoxin inhibits Wnt-beta-catenin signalling through dishevelled. Nat. Cell Biol. 2006;8:501&#x2013;508. doi: 10.1038/ncb1405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1405</ArticleId><ArticleId IdType="pubmed">16604061</ArticleId></ArticleIdList></Reference><Reference><Citation>Tothova Z., Gilliland D.G. FoxO transcription factors and stem cell homeostasis: Insights from the hematopoietic system. Cell Stem. Cell. 2007;1:140&#x2013;152. doi: 10.1016/j.stem.2007.07.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2007.07.017</ArticleId><ArticleId IdType="pubmed">18371346</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuikov S., Levi B.P., Smith M.L., Morrison S.J. Prdm16 promotes stem cell maintenance in multiple tissues, partly by regulating oxidative stress. Nat. Cell Biol. 2010;12:999&#x2013;1006. doi: 10.1038/ncb2101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2101</ArticleId><ArticleId IdType="pmc">PMC2948585</ArticleId><ArticleId IdType="pubmed">20835244</ArticleId></ArticleIdList></Reference><Reference><Citation>Kajla S., Mondol A.S., Nagasawa A., Zhang Y., Kato M., Matsuno K., Yabe-Nishimura C., Kamata T. A crucial role for Nox 1 in redox-dependent regulation of Wnt-beta-catenin signaling. FASEB J. 2012;26:2049&#x2013;2059. doi: 10.1096/fj.11-196360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.11-196360</ArticleId><ArticleId IdType="pubmed">22278940</ArticleId></ArticleIdList></Reference><Reference><Citation>Klotz L.O., Steinbrenner H. Cellular adaptation to xenobiotics: Interplay between xenosensors, reactive oxygen species and FOXO transcription factors. Redox Biol. 2017;13:646&#x2013;654. doi: 10.1016/j.redox.2017.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2017.07.015</ArticleId><ArticleId IdType="pmc">PMC5558470</ArticleId><ArticleId IdType="pubmed">28818793</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonelli C., Chio I.I.C., Tuveson D.A. Transcriptional Regulation by Nrf2. Antioxid. Redox Signal. 2018;29:1727&#x2013;1745. doi: 10.1089/ars.2017.7342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2017.7342</ArticleId><ArticleId IdType="pmc">PMC6208165</ArticleId><ArticleId IdType="pubmed">28899199</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabe Y., Ando K., Hirao S., Yoshida M., Handa H. Redox regulation of NF-kappaB activation: Distinct redox regulation between the cytoplasm and the nucleus. Antioxid. Redox Signal. 2005;7:395&#x2013;403. doi: 10.1089/ars.2005.7.395.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2005.7.395</ArticleId><ArticleId IdType="pubmed">15706086</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan M.J., Liu Z.G. Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res. 2011;21:103&#x2013;115. doi: 10.1038/cr.2010.178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2010.178</ArticleId><ArticleId IdType="pmc">PMC3193400</ArticleId><ArticleId IdType="pubmed">21187859</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha S., Buttari B., Panieri E., Profumo E., Saso L. An Overview of Nrf2 Signaling Pathway and Its Role in Inflammation. Molecules. 2020;25:5474. doi: 10.3390/molecules25225474.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25225474</ArticleId><ArticleId IdType="pmc">PMC7700122</ArticleId><ArticleId IdType="pubmed">33238435</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaspar J.W., Niture S.K., Jaiswal A.K. Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic. Biol. Med. 2009;47:1304&#x2013;1309. doi: 10.1016/j.freeradbiomed.2009.07.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2009.07.035</ArticleId><ArticleId IdType="pmc">PMC2763938</ArticleId><ArticleId IdType="pubmed">19666107</ArticleId></ArticleIdList></Reference><Reference><Citation>Canning P., Sorrell F.J., Bullock A.N. Structural basis of Keap1 interactions with Nrf2. Free Radic. Biol. Med. 2015;88:101&#x2013;107. doi: 10.1016/j.freeradbiomed.2015.05.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2015.05.034</ArticleId><ArticleId IdType="pmc">PMC4668279</ArticleId><ArticleId IdType="pubmed">26057936</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki T., Yamamoto M. Molecular basis of the Keap1-Nrf2 system. Free Radic. Biol. Med. 2015;88:93&#x2013;100. doi: 10.1016/j.freeradbiomed.2015.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2015.06.006</ArticleId><ArticleId IdType="pubmed">26117331</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares M.A., Cohen O.D., Low Y.C., Sartor R.A., Ellison T., Anil U., Anzai L., Chang J.B., Saadeh P.B., Rabbani P.S., et al. Restoration of Nrf2 Signaling Normalizes the Regenerative Niche. Diabetes. 2016;65:633&#x2013;646. doi: 10.2337/db15-0453.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db15-0453</ArticleId><ArticleId IdType="pmc">PMC5314719</ArticleId><ArticleId IdType="pubmed">26647385</ArticleId></ArticleIdList></Reference><Reference><Citation>Klotz L.O., Sanchez-Ramos C., Prieto-Arroyo I., Urbanek P., Steinbrenner H., Monsalve M. Redox regulation of FoxO transcription factors. Redox Biol. 2015;6:51&#x2013;72. doi: 10.1016/j.redox.2015.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2015.06.019</ArticleId><ArticleId IdType="pmc">PMC4511623</ArticleId><ArticleId IdType="pubmed">26184557</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Crisostomo N.P., Rodriguez M.E., Rivas-Arancibia S. Oxidative stress activates the transcription factors FoxO 1a and FoxO 3a in the hippocampus of rats exposed to low doses of ozone. Oxid. Med. Cell Longev. 2014;2014:805764. doi: 10.1155/2014/805764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/805764</ArticleId><ArticleId IdType="pmc">PMC4055648</ArticleId><ArticleId IdType="pubmed">24967006</ArticleId></ArticleIdList></Reference><Reference><Citation>Staal F.J., Luis T.C., Tiemessen M.M. WNT signalling in the immune system: WNT is spreading its wings. Nat. Rev. Immunol. 2008;8:581&#x2013;593. doi: 10.1038/nri2360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2360</ArticleId><ArticleId IdType="pubmed">18617885</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulua A.C., Simon A., Maddipati R., Pelletier M., Park H., Kim K.Y., Sack M.N., Kastner D.L., Siegel R.M. Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS) J. Exp. Med. 2011;208:519&#x2013;533. doi: 10.1084/jem.20102049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20102049</ArticleId><ArticleId IdType="pmc">PMC3058571</ArticleId><ArticleId IdType="pubmed">21282379</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakahira K., Haspel J.A., Rathinam V.A., Lee S.J., Dolinay T., Lam H.C., Englert J.A., Rabinovitch M., Cernadas M., Kim H.P., et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 2011;12:222&#x2013;230. doi: 10.1038/ni.1980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1980</ArticleId><ArticleId IdType="pmc">PMC3079381</ArticleId><ArticleId IdType="pubmed">21151103</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou R., Yazdi A.S., Menu P., Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011;469:221&#x2013;225. doi: 10.1038/nature09663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09663</ArticleId><ArticleId IdType="pubmed">21124315</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou R., Tardivel A., Thorens B., Choi I., Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 2010;11:136&#x2013;140. doi: 10.1038/ni.1831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1831</ArticleId><ArticleId IdType="pubmed">20023662</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J., Chng W.J. Roles of thioredoxin binding protein (TXNIP) in oxidative stress, apoptosis and cancer. Mitochondrion. 2013;13:163&#x2013;169. doi: 10.1016/j.mito.2012.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2012.06.004</ArticleId><ArticleId IdType="pubmed">22750447</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S., Chen F., Yin Q., Wang D., Han W., Zhang Y. Reactive Oxygen Species Interact With NLRP3 Inflammasomes and Are Involved in the Inflammation of Sepsis: From Mechanism to Treatment of Progression. Front. Physiol. 2020;11:571810. doi: 10.3389/fphys.2020.571810.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.571810</ArticleId><ArticleId IdType="pmc">PMC7723971</ArticleId><ArticleId IdType="pubmed">33324236</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kruger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271&#x2013;280. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi F., Qian S., Zhang S., Zhang Z. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem Biophys Res. Commun. 2020;526:135&#x2013;140. doi: 10.1016/j.bbrc.2020.03.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.03.044</ArticleId><ArticleId IdType="pmc">PMC7156119</ArticleId><ArticleId IdType="pubmed">32199615</ArticleId></ArticleIdList></Reference><Reference><Citation>Hikmet F., Mear L., Edvinsson A., Micke P., Uhlen M., Lindskog C. The protein expression profile of ACE2 in human tissues. Mol. Syst. Biol. 2020;16:e9610. doi: 10.15252/msb.20209610.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.20209610</ArticleId><ArticleId IdType="pmc">PMC7383091</ArticleId><ArticleId IdType="pubmed">32715618</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhlen M., Karlsson M.J., Zhong W., Tebani A., Pou C., Mikes J., Lakshmikanth T., Forsstrom B., Edfors F., Odeberg J., et al. A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. Science. 2019;366:eaax9198. doi: 10.1126/science.aax9198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aax9198</ArticleId><ArticleId IdType="pubmed">31857451</ArticleId></ArticleIdList></Reference><Reference><Citation>Reikine S., Nguyen J.B., Modis Y. Pattern Recognition and Signaling Mechanisms of RIG-I and MDA5. Front. Immunol. 2014;5:342. doi: 10.3389/fimmu.2014.00342.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00342</ArticleId><ArticleId IdType="pmc">PMC4107945</ArticleId><ArticleId IdType="pubmed">25101084</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim Y.X., Ng Y.L., Tam J.P., Liu D.X. Human Coronaviruses: A Review of Virus-Host Interactions. Diseases. 2016;4:26. doi: 10.3390/diseases4030026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diseases4030026</ArticleId><ArticleId IdType="pmc">PMC5456285</ArticleId><ArticleId IdType="pubmed">28933406</ArticleId></ArticleIdList></Reference><Reference><Citation>Hur S. Double-Stranded RNA Sensors and Modulators in Innate Immunity. Annu. Rev. Immunol. 2019;37:349&#x2013;375. doi: 10.1146/annurev-immunol-042718-041356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-042718-041356</ArticleId><ArticleId IdType="pmc">PMC7136661</ArticleId><ArticleId IdType="pubmed">30673536</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald K.A., Kagan J.C. Toll-like Receptors and the Control of Immunity. Cell. 2020;180:1044&#x2013;1066. doi: 10.1016/j.cell.2020.02.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.041</ArticleId><ArticleId IdType="pmc">PMC9358771</ArticleId><ArticleId IdType="pubmed">32164908</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieto-Torres J.L., Verdia-Baguena C., Jimenez-Guardeno J.M., Regla-Nava J.A., Castano-Rodriguez C., Fernandez-Delgado R., Torres J., Aguilella V.M., Enjuanes L. Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome. Virology. 2015;485:330&#x2013;339. doi: 10.1016/j.virol.2015.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.08.010</ArticleId><ArticleId IdType="pmc">PMC4619128</ArticleId><ArticleId IdType="pubmed">26331680</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues T.S., de Sa K.S.G., Ishimoto A.Y., Becerra A., Oliveira S., Almeida L., Goncalves A.V., Perucello D.B., Andrade W.A., Castro R., et al. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J. Exp. Med. 2021;218:e20201707. doi: 10.1084/jem.20201707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20201707</ArticleId><ArticleId IdType="pmc">PMC7684031</ArticleId><ArticleId IdType="pubmed">33231615</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C., Lu W., Zhang Y., Zhang G., Shi X., Hisada Y., Grover S.P., Zhang X., Li L., Xiang B., et al. Inflammasome Activation Triggers Blood Clotting and Host Death through Pyroptosis. Immunity. 2019;50:1401&#x2013;1411. doi: 10.1016/j.immuni.2019.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2019.04.003</ArticleId><ArticleId IdType="pmc">PMC6791531</ArticleId><ArticleId IdType="pubmed">31076358</ArticleId></ArticleIdList></Reference><Reference><Citation>Middeldorp S., Coppens M., van Haaps T.F., Foppen M., Vlaar A.P., Muller M.C.A., Bouman C.C.S., Beenen L.F.M., Kootte R.S., Heijmans J., et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J. Thromb Haemost. 2020;18:1995&#x2013;2002. doi: 10.1111/jth.14888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14888</ArticleId><ArticleId IdType="pmc">PMC7497052</ArticleId><ArticleId IdType="pubmed">32369666</ArticleId></ArticleIdList></Reference><Reference><Citation>Miorin L., Kehrer T., Sanchez-Aparicio M.T., Zhang K., Cohen P., Patel R.S., Cupic A., Makio T., Mei M., Moreno E., et al. SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling. Proc. Natl. Acad. Sci. USA. 2020;117:28344&#x2013;28354. doi: 10.1073/pnas.2016650117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2016650117</ArticleId><ArticleId IdType="pmc">PMC7668094</ArticleId><ArticleId IdType="pubmed">33097660</ArticleId></ArticleIdList></Reference><Reference><Citation>Arunachalam P.S., Wimmers F., Mok C.K.P., Perera R.A.P.M., Scott M., Hagan T., Sigal N., Feng Y., Bristow L., Tak-Yin T.O., et al. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science. 2020;369:1210&#x2013;1220. doi: 10.1126/science.abc6261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6261</ArticleId><ArticleId IdType="pmc">PMC7665312</ArticleId><ArticleId IdType="pubmed">32788292</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco-Melo D., Nilsson-Payant B.E., Liu W.C., Uhl S., Hoagland D., Moller R., Jordan T.X., Oishi K., Panis M., Sachs D., et al. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19. Cell. 2020;181:1036&#x2013;1045. doi: 10.1016/j.cell.2020.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.026</ArticleId><ArticleId IdType="pmc">PMC7227586</ArticleId><ArticleId IdType="pubmed">32416070</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas C., Klein J., Sundaram M., Liu F., Wong P., Silva J., Mao T., Oh J.E., Tokuyama M., Lu P., et al. Kinetics of antibody responses dictate COVID-19 outcome. medRxiv. 2020</Citation></Reference><Reference><Citation>Vabret N., Britton G.J., Gruber C., Hegde S., Kim J., Kuksin M., Levantovsky R., Malle L., Moreira A., Park M.D., et al. Immunology of COVID-19: Current State of the Science. Immunity. 2020;52:910&#x2013;941. doi: 10.1016/j.immuni.2020.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.05.002</ArticleId><ArticleId IdType="pmc">PMC7200337</ArticleId><ArticleId IdType="pubmed">32505227</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan S.C., Zakowski P., Tran H.P., Smith E.A., Gaultier C., Marks G., Zabner R., Lowenstein H., Oft J., Bluen B., et al. Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia. Clin. Infect. Dis. 2020;71:3168&#x2013;3173. doi: 10.1093/cid/ciaa812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa812</ArticleId><ArticleId IdType="pmc">PMC7337689</ArticleId><ArticleId IdType="pubmed">32575124</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvelli J., Demaria O., Vely F., Batista L., Chouaki B.N., Fares J., Carpentier S., Thibult M.L., Morel A., Remark R., et al. Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis. Nature. 2020;588:146&#x2013;150. doi: 10.1038/s41586-020-2600-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2600-6</ArticleId><ArticleId IdType="pmc">PMC7116884</ArticleId><ArticleId IdType="pubmed">32726800</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomson T.M., Toscano-Guerra E., Casis E., Paciucci R. C1 esterase inhibitor and the contact system in COVID-19. Br. J. Haematol. 2020;190:520&#x2013;524. doi: 10.1111/bjh.16938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.16938</ArticleId><ArticleId IdType="pmc">PMC7323335</ArticleId><ArticleId IdType="pubmed">32531085</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlaar A.P.J., de Bruin S., Busch M., Timmermans S.A.M.E., van Zeggeren I.E., Koning R., Ter H.L., Bulle E.B., van Baarle F.E.H.P., van de Poll M.C.G., et al. Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): An exploratory, open-label, phase 2 randomised controlled trial. Lancet Rheumatol. 2020;2:e764&#x2013;e773. doi: 10.1016/S2665-9913(20)30341-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30341-6</ArticleId><ArticleId IdType="pmc">PMC7521913</ArticleId><ArticleId IdType="pubmed">33015643</ArticleId></ArticleIdList></Reference><Reference><Citation>Urwyler P., Moser S., Charitos P., Heijnen I.A.F.M., Rudin M., Sommer G., Giannetti B.M., Bassetti S., Sendi P., Trendelenburg M., et al. Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System. Front. Immunol. 2020;11:2072. doi: 10.3389/fimmu.2020.02072.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.02072</ArticleId><ArticleId IdType="pmc">PMC7456998</ArticleId><ArticleId IdType="pubmed">32922409</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay M.Z., Poh C.M., Renia L., MacAry P.A., Ng L.F.P. The trinity of COVID-19: Immunity, inflammation and intervention. Nat. Rev. Immunol. 2020;20:363&#x2013;374. doi: 10.1038/s41577-020-0311-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0311-8</ArticleId><ArticleId IdType="pmc">PMC7187672</ArticleId><ArticleId IdType="pubmed">32346093</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X. COVID-19: Immunopathology and its implications for therapy. Nat. Rev. Immunol. 2020;20:269&#x2013;270. doi: 10.1038/s41577-020-0308-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0308-3</ArticleId><ArticleId IdType="pmc">PMC7143200</ArticleId><ArticleId IdType="pubmed">32273594</ArticleId></ArticleIdList></Reference><Reference><Citation>Gudbjartsson D.F., Norddahl G.L., Melsted P., Gunnarsdottir K., Holm H., Eythorsson E., Arnthorsson A.O., Helgason D., Bjarnadottir K., Ingvarsson R.F., et al. Humoral Immune Response to SARS-CoV-2 in Iceland. N. Engl. J. Med. 2020;383:1724&#x2013;1734. doi: 10.1056/NEJMoa2026116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2026116</ArticleId><ArticleId IdType="pmc">PMC7494247</ArticleId><ArticleId IdType="pubmed">32871063</ArticleId></ArticleIdList></Reference><Reference><Citation>Wajnberg A., Mansour M., Leven E., Bouvier N.M., Patel G., Firpo-Betancourt A., Mendu R., Jhang J., Arinsburg S., Gitman M., et al. Humoral response and PCR positivity in patients with COVID-19 in the New York City region, USA: An observational study. Lancet Microbe. 2020;1:e283&#x2013;e289. doi: 10.1016/S2666-5247(20)30120-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30120-8</ArticleId><ArticleId IdType="pmc">PMC7518831</ArticleId><ArticleId IdType="pubmed">33015652</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephens D.S., McElrath M.J. COVID-19 and the Path to Immunity. JAMA. 2020;324:1279&#x2013;1281. doi: 10.1001/jama.2020.16656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.16656</ArticleId><ArticleId IdType="pubmed">32915201</ArticleId></ArticleIdList></Reference><Reference><Citation>Suthar M.S., Zimmerman M.G., Kauffman R.C., Mantus G., Linderman S.L., Hudson W.H., Vanderheiden A., Nyhoff L., Davis C.W., Adekunle O., et al. Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients. Cell Rep. Med. 2020;1:100040. doi: 10.1016/j.xcrm.2020.100040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2020.100040</ArticleId><ArticleId IdType="pmc">PMC7276302</ArticleId><ArticleId IdType="pubmed">32835303</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbiani D.F., Gaebler C., Muecksch F., Lorenzi J.C.C., Wang Z., Cho A., Agudelo M., Barnes C.O., Gazumyan A., Finkin S., et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature. 2020;584:437&#x2013;442. doi: 10.1038/s41586-020-2456-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2456-9</ArticleId><ArticleId IdType="pmc">PMC7442695</ArticleId><ArticleId IdType="pubmed">32555388</ArticleId></ArticleIdList></Reference><Reference><Citation>Lumley S.F., O&#x2019;Donnell D., Stoesser N.E., Matthews P.C., Howarth A., Hatch S.B., Marsden B.D., Cox S., James T., Warren F., et al. Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers. N. Engl. J. Med. 2021;384:533&#x2013;540. doi: 10.1056/NEJMoa2034545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2034545</ArticleId><ArticleId IdType="pmc">PMC7781098</ArticleId><ArticleId IdType="pubmed">33369366</ArticleId></ArticleIdList></Reference><Reference><Citation>Dan J.M., Mateus J., Kato Y., Hastie K.M., Yu E.D., Faliti C.E., Grifoni A., Ramirez S.I., Haupt S., Frazier A., et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. 2021;371:eabf4063. doi: 10.1126/science.abf4063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf4063</ArticleId><ArticleId IdType="pmc">PMC7919858</ArticleId><ArticleId IdType="pubmed">33408181</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramlall V., Thangaraj P.M., Meydan C., Foox J., Butler D., May B., De Freitas J.K., Glicksberg B.S., Mason C.E., Tatonetti N.P., et al. Identification of Immune complement function as a determinant of adverse SARS-CoV-2 infection outcome. medRxiv. 2020 doi: 10.1101/2020.05.05.20092452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.05.20092452</ArticleId><ArticleId IdType="pmc">PMC7809634</ArticleId><ArticleId IdType="pubmed">32747830</ArticleId></ArticleIdList></Reference><Reference><Citation>Grifoni A., Weiskopf D., Ramirez S.I., Mateus J., Dan J.M., Moderbacher C.R., Rawlings S.A., Sutherland A., Premkumar L., Jadi R.S., et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. 2020;181:1489&#x2013;1501. doi: 10.1016/j.cell.2020.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.015</ArticleId><ArticleId IdType="pmc">PMC7237901</ArticleId><ArticleId IdType="pubmed">32473127</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J.Y., Wang X.M., Xing X., Xu Z., Zhang C., Song J.W., Fan X., Xia P., Fu J.L., Wang S.Y., et al. Single-cell landscape of immunological responses in patients with COVID-19. Nat. Immunol. 2020;21:1107&#x2013;1118. doi: 10.1038/s41590-020-0762-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0762-x</ArticleId><ArticleId IdType="pubmed">32788748</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Y., Mentzer A.J., Liu G., Yao X., Yin Z., Dong D., Dejnirattisai W., Rostron T., Supasa P., Liu C., et al. Broad and strong memory CD4 (+) and CD8 (+) T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients. bioRxiv. 2020 doi: 10.1101/2020.06.05.134551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.06.05.134551</ArticleId><ArticleId IdType="pmc">PMC7611020</ArticleId><ArticleId IdType="pubmed">32887977</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipsitch M., Grad Y.H., Sette A., Crotty S. Cross-reactive memory T cells and herd immunity to SARS-CoV-2. Nat. Rev. Immunol. 2020;20:709&#x2013;713. doi: 10.1038/s41577-020-00460-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-00460-4</ArticleId><ArticleId IdType="pmc">PMC7537578</ArticleId><ArticleId IdType="pubmed">33024281</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng K.W., Faulkner N., Cornish G.H., Rosa A., Harvey R., Hussain S., Ulferts R., Earl C., Wrobel A.G., Benton D.J., et al. Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. Science. 2020;370:1339&#x2013;1343. doi: 10.1126/science.abe1107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abe1107</ArticleId><ArticleId IdType="pmc">PMC7857411</ArticleId><ArticleId IdType="pubmed">33159009</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson E.M., Diorio C., Goodwin E.C., McNerney K.O., Weirick M.E., Gouma S., Bolton M.J., Arevalo C.P., Chase J., Hicks P., et al. SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19. medRxiv. 2020 doi: 10.1101/2020.08.17.20176552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.08.17.20176552</ArticleId><ArticleId IdType="pmc">PMC7799010</ArticleId><ArticleId IdType="pubmed">33263756</ArticleId></ArticleIdList></Reference><Reference><Citation>Tetro J.A. Is COVID-19 receiving ADE from other coronaviruses? Microbes Infect. 2020;22:72&#x2013;73. doi: 10.1016/j.micinf.2020.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2020.02.006</ArticleId><ArticleId IdType="pmc">PMC7102551</ArticleId><ArticleId IdType="pubmed">32092539</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaume M., Yip M.S., Cheung C.Y., Leung H.L., Li P.H., Kien F., Dutry I., Callendret B., Escriou N., Altmeyer R., et al. Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcgammaR pathway. J. Virol. 2011;85:10582&#x2013;10597. doi: 10.1128/JVI.00671-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00671-11</ArticleId><ArticleId IdType="pmc">PMC3187504</ArticleId><ArticleId IdType="pubmed">21775467</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.F., Tseng S.P., Yen C.H., Yang J.Y., Tsao C.H., Shen C.W., Chen K.H., Liu F.T., Liu W.T., Chen Y.M., et al. Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins. Biochem Biophys Res. Commun. 2014;451:208&#x2013;214. doi: 10.1016/j.bbrc.2014.07.090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2014.07.090</ArticleId><ArticleId IdType="pmc">PMC7092860</ArticleId><ArticleId IdType="pubmed">25073113</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L., Wei Q., Lin Q., Fang J., Wang H., Kwok H., Tang H., Nishiura K., Peng J., Tan Z., et al. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight. 2019;4:e123158. doi: 10.1172/jci.insight.123158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.123158</ArticleId><ArticleId IdType="pmc">PMC6478436</ArticleId><ArticleId IdType="pubmed">30830861</ArticleId></ArticleIdList></Reference><Reference><Citation>Suhail S., Zajac J., Fossum C., Lowater H., McCracken C., Severson N., Laatsch B., Narkiewicz-Jodko A., Johnson B., Liebau J., et al. Role of Oxidative Stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) Infection: A Review. Protein J. 2020;39:644&#x2013;656. doi: 10.1007/s10930-020-09935-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10930-020-09935-8</ArticleId><ArticleId IdType="pmc">PMC7587547</ArticleId><ArticleId IdType="pubmed">33106987</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernyak B.V., Popova E.N., Prikhodko A.S., Grebenchikov O.A., Zinovkina L.A., Zinovkin R.A. COVID-19 and Oxidative Stress. Biochemistry. 2020;85:1543&#x2013;1553. doi: 10.1134/S0006297920120068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0006297920120068</ArticleId><ArticleId IdType="pmc">PMC7768996</ArticleId><ArticleId IdType="pubmed">33705292</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpenito L., D&#x2019;Ercole M., Porta F., Di B.E., Doi P., Fagara G.R., Rey R., Bulfamante G. The autopsy at the time of SARS-CoV-2: Protocol and lessons. Ann. Diagn. Pathol. 2020;48:151562. doi: 10.1016/j.anndiagpath.2020.151562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anndiagpath.2020.151562</ArticleId><ArticleId IdType="pmc">PMC7334655</ArticleId><ArticleId IdType="pubmed">32653819</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C., Liu S., Zhao P., Liu H., Zhu L., et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420&#x2013;422. doi: 10.1016/S2213-2600(20)30076-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30076-X</ArticleId><ArticleId IdType="pmc">PMC7164771</ArticleId><ArticleId IdType="pubmed">32085846</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecchini R., Cecchini A.L. SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression. Med. Hypotheses. 2020;143:110102. doi: 10.1016/j.mehy.2020.110102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110102</ArticleId><ArticleId IdType="pmc">PMC7357498</ArticleId><ArticleId IdType="pubmed">32721799</ArticleId></ArticleIdList></Reference><Reference><Citation>Casola A., Burger N., Liu T., Jamaluddin M., Brasier A.R., Garofalo R.P. Oxidant tone regulates RANTES gene expression in airway epithelial cells infected with respiratory syncytial virus. Role in viral-induced interferon regulatory factor activation. J. Biol. Chem. 2001;276:19715&#x2013;19722. doi: 10.1074/jbc.M101526200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M101526200</ArticleId><ArticleId IdType="pubmed">11259439</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosakote Y.M., Jantzi P.D., Esham D.L., Spratt H., Kurosky A., Casola A., Garofalo R.P. Viral-mediated inhibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis. Am. J. Respir Crit. Care Med. 2011;183:1550&#x2013;1560. doi: 10.1164/rccm.201010-1755OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201010-1755OC</ArticleId><ArticleId IdType="pmc">PMC3137144</ArticleId><ArticleId IdType="pubmed">21471094</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosmider B., Messier E.M., Janssen W.J., Nahreini P., Wang J., Hartshorn K.L., Mason R.J. Nrf2 protects human alveolar epithelial cells against injury induced by influenza A virus. Respir Res. 2012;13:43. doi: 10.1186/1465-9921-13-43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1465-9921-13-43</ArticleId><ArticleId IdType="pmc">PMC3520784</ArticleId><ArticleId IdType="pubmed">22672594</ArticleId></ArticleIdList></Reference><Reference><Citation>Selemidis S., Seow H.J., Broughton B.R., Vinh A., Bozinovski S., Sobey C.G., Drummond G.R., Vlahos R. Nox1 oxidase suppresses influenza a virus-induced lung inflammation and oxidative stress. PLoS ONE. 2013;8:e60792. doi: 10.1371/journal.pone.0060792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0060792</ArticleId><ArticleId IdType="pmc">PMC3620107</ArticleId><ArticleId IdType="pubmed">23577160</ArticleId></ArticleIdList></Reference><Reference><Citation>Amatore D., Sgarbanti R., Aquilano K., Baldelli S., Limongi D., Civitelli L., Nencioni L., Garaci E., Ciriolo M.R., Palamara A.T. Influenza virus replication in lung epithelial cells depends on redox-sensitive pathways activated by NOX4-derived ROS. Cell Microbiol. 2015;17:131&#x2013;145. doi: 10.1111/cmi.12343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cmi.12343</ArticleId><ArticleId IdType="pmc">PMC4311438</ArticleId><ArticleId IdType="pubmed">25154738</ArticleId></ArticleIdList></Reference><Reference><Citation>Padhan K., Minakshi R., Towheed M.A.B., Jameel S. Severe acute respiratory syndrome coronavirus 3a protein activates the mitochondrial death pathway through p38 MAP kinase activation. J. Gen. Virol. 2008;89:1960&#x2013;1969. doi: 10.1099/vir.0.83665-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.83665-0</ArticleId><ArticleId IdType="pubmed">18632968</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Brand J.M., Haagmans B.L., Osterhaus A.D., Kuiken T. The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models. J. Comp. Pathol. 2014;151:83&#x2013;112. doi: 10.1016/j.jcpa.2014.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcpa.2014.01.004</ArticleId><ArticleId IdType="pmc">PMC7094469</ArticleId><ArticleId IdType="pubmed">24581932</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung T.S., Liu D.X. Human Coronavirus: Host-Pathogen Interaction. Annu. Rev. Microbiol. 2019;73:529&#x2013;557. doi: 10.1146/annurev-micro-020518-115759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-micro-020518-115759</ArticleId><ArticleId IdType="pubmed">31226023</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao H., Lan D., Duan Z., Liu Z., Min J., Zhang L., Huang J., Su J., Chen S., Xu A. Upregulation of mitochondrial gene expression in PBMC from convalescent SARS patients. J. Clin. Immunol. 2006;26:546&#x2013;554. doi: 10.1007/s10875-006-9046-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-006-9046-y</ArticleId><ArticleId IdType="pmc">PMC7086694</ArticleId><ArticleId IdType="pubmed">17024565</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y.H., Tseng C.P., Cheng M.L., Ho H.Y., Shih S.R., Chiu D.T. Glucose-6-phosphate dehydrogenase deficiency enhances human coronavirus 229E infection. J. Infect. Dis. 2008;197:812&#x2013;816. doi: 10.1086/528377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/528377</ArticleId><ArticleId IdType="pmc">PMC7199897</ArticleId><ArticleId IdType="pubmed">18269318</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho H.Y., Cheng M.L., Weng S.F., Chang L., Yeh T.T., Shih S.R., Chiu D.T. Glucose-6-phosphate dehydrogenase deficiency enhances enterovirus 71 infection. J. Gen. Virol. 2008;89:2080&#x2013;2089. doi: 10.1099/vir.0.2008/001404-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.2008/001404-0</ArticleId><ArticleId IdType="pubmed">18753216</ArticleId></ArticleIdList></Reference><Reference><Citation>Elhabyan A., Elyaacoub S., Sanad E., Abukhadra A., Elhabyan A., Dinu V. The role of host genetics in susceptibility to severe viral infections in humans and insights into host genetics of severe COVID-19: A systematic review. Virus Res. 2020;289:198163. doi: 10.1016/j.virusres.2020.198163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.198163</ArticleId><ArticleId IdType="pmc">PMC7480444</ArticleId><ArticleId IdType="pubmed">32918943</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrasfay T., Goldman N. Reductions in 2020 US life expectancy due to COVID-19 and the disproportionate impact on the Black and Latino populations. Proc. Natl. Acad. Sci. USA. 2021;118:e2014746118. doi: 10.1073/pnas.2014746118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2014746118</ArticleId><ArticleId IdType="pmc">PMC7865122</ArticleId><ArticleId IdType="pubmed">33446511</ArticleId></ArticleIdList></Reference><Reference><Citation>Pincemail J., Cavalier E., Charlier C., Cheramy-Bien J.P., Brevers E., Courtois A., Fadeur M., Meziane S., Goff C.L., Misset B., et al. Oxidative Stress Status in COVID-19 Patients Hospitalized in Intensive Care Unit for Severe Pneumonia. A Pilot Study. Antioxidants. 2021;10:257. doi: 10.3390/antiox10020257.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10020257</ArticleId><ArticleId IdType="pmc">PMC7914603</ArticleId><ArticleId IdType="pubmed">33562403</ArticleId></ArticleIdList></Reference><Reference><Citation>Karkhanei B., Talebi G.E., Mehri F. Evaluation of oxidative stress level: Total antioxidant capacity, total oxidant status and glutathione activity in patients with COVID-19. New Microbes New Infect. 2021;42:100897. doi: 10.1016/j.nmni.2021.100897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmni.2021.100897</ArticleId><ArticleId IdType="pmc">PMC8127525</ArticleId><ArticleId IdType="pubmed">34026228</ArticleId></ArticleIdList></Reference><Reference><Citation>Gadotti A.C., Lipinski A.L., Vasconcellos F.T., Marqueze L.F., Cunha E.B., Campos A.C., Oliveira C.F., Amaral A.N., Baena C.P., Telles J.P., et al. Susceptibility of the patients infected with SARS-CoV2 to oxidative stress and possible interplay with severity of the disease. Free Radic. Biol. Med. 2021;165:184&#x2013;190. doi: 10.1016/j.freeradbiomed.2021.01.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2021.01.044</ArticleId><ArticleId IdType="pmc">PMC7846460</ArticleId><ArticleId IdType="pubmed">33524532</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarkovic N., Orehovec B., Milkovic L., Barsic B., Tatzber F., Wonisch W., Tarle M., Kmet M., Mataic A., Jakovcevic A., et al. Preliminary Findings on the Association of the Lipid Peroxidation Product 4-Hydroxynonenal with the Lethal Outcome of Aggressive COVID-19. Antioxidants. 2021;10:1341. doi: 10.3390/antiox10091341.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10091341</ArticleId><ArticleId IdType="pmc">PMC8472532</ArticleId><ArticleId IdType="pubmed">34572973</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Fernandez M., Aller R., Heredia-Rodriguez M., Gomez-Sanchez E., Martinez-Paz P., Gonzalo-Benito H., Sanchez-de P.L., Gorgojo O., Carnicero-Frutos I., Tamayo E., et al. Lipid peroxidation as a hallmark of severity in COVID-19 patients. Redox Biol. 2021;48:102181. doi: 10.1016/j.redox.2021.102181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2021.102181</ArticleId><ArticleId IdType="pmc">PMC8572041</ArticleId><ArticleId IdType="pubmed">34768063</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawy M.A., Yasseen B.A., El-Messiery R.M., Abdel-Rahman E.A., Elkhodiry A.A., Kamel A.G., El-Sayed H., Shedra A.M., Hamdy R., Zidan M., et al. Neutrophil-mediated oxidative stress and albumin structural damage predict COVID-19-associated mortality. Elife. 2021;10:e69417. doi: 10.7554/eLife.69417.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.69417</ArticleId><ArticleId IdType="pmc">PMC8641949</ArticleId><ArticleId IdType="pubmed">34821549</ArticleId></ArticleIdList></Reference><Reference><Citation>Babior B.M. Oxidants from phagocytes: Agents of defense and destruction. Blood. 1984;64:959&#x2013;966. doi: 10.1182/blood.V64.5.959.959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V64.5.959.959</ArticleId><ArticleId IdType="pubmed">6386073</ArticleId></ArticleIdList></Reference><Reference><Citation>Warnatsch A., Tsourouktsoglou T.D., Branzk N., Wang Q., Reincke S., Herbst S., Gutierrez M., Papayannopoulos V. Reactive Oxygen Species Localization Programs Inflammation to Clear Microbes of Different Size. Immunity. 2017;46:421&#x2013;432. doi: 10.1016/j.immuni.2017.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.02.013</ArticleId><ArticleId IdType="pmc">PMC5965455</ArticleId><ArticleId IdType="pubmed">28314592</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Prete A., Zaccagnino P., Di P.M., Saltarella M., Oliveros C.C., Nico B., Santoro G., Lorusso M. Role of mitochondria and reactive oxygen species in dendritic cell differentiation and functions. Free Radic. Biol. Med. 2008;44:1443&#x2013;1451. doi: 10.1016/j.freeradbiomed.2007.12.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2007.12.037</ArticleId><ArticleId IdType="pubmed">18242195</ArticleId></ArticleIdList></Reference><Reference><Citation>Herb M., Gluschko A., Wiegmann K., Farid A., Wolf A., Utermohlen O., Krut O., Kronke M., Schramm M. Mitochondrial reactive oxygen species enable proinflammatory signaling through disulfide linkage of NEMO. Sci. Signal. 2019;12:eaar5926. doi: 10.1126/scisignal.aar5926.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.aar5926</ArticleId><ArticleId IdType="pubmed">30755476</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y.H., Kumar A., Chang C.H., Pyaram K. Reactive Oxygen Species Regulate the Inflammatory Function of NKT Cells through Promyelocytic Leukemia Zinc Finger. J. Immunol. 2017;199:3478&#x2013;3487. doi: 10.4049/jimmunol.1700567.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1700567</ArticleId><ArticleId IdType="pmc">PMC5685185</ArticleId><ArticleId IdType="pubmed">29021374</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Z., Garg S.K., Kipnis J., Banerjee R. Extracellular redox modulation by regulatory T cells. Nat. Chem. Biol. 2009;5:721&#x2013;723. doi: 10.1038/nchembio.212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.212</ArticleId><ArticleId IdType="pmc">PMC2760945</ArticleId><ArticleId IdType="pubmed">19718041</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsue H., Edelbaum D., Shalhevet D., Mizumoto N., Yang C., Mummert M.E., Oeda J., Masayasu H., Takashima A. Generation and function of reactive oxygen species in dendritic cells during antigen presentation. J. Immunol. 2003;171:3010&#x2013;3018. doi: 10.4049/jimmunol.171.6.3010.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.171.6.3010</ArticleId><ArticleId IdType="pubmed">12960326</ArticleId></ArticleIdList></Reference><Reference><Citation>Los M., Schenk H., Hexel K., Baeuerle P.A., Droge W., Schulze-Osthoff K. IL-2 gene expression and NF-kappa B activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J. 1995;14:3731&#x2013;3740. doi: 10.1002/j.1460-2075.1995.tb00043.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1995.tb00043.x</ArticleId><ArticleId IdType="pmc">PMC394448</ArticleId><ArticleId IdType="pubmed">7641692</ArticleId></ArticleIdList></Reference><Reference><Citation>Suthanthiran M., Anderson M.E., Sharma V.K., Meister A. Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens. Proc. Natl. Acad Sci. USA. 1990;87:3343&#x2013;3347. doi: 10.1073/pnas.87.9.3343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.87.9.3343</ArticleId><ArticleId IdType="pmc">PMC53896</ArticleId><ArticleId IdType="pubmed">1970635</ArticleId></ArticleIdList></Reference><Reference><Citation>Kesarwani P., Murali A.K., Al-Khami A.A., Mehrotra S. Redox regulation of T-cell function: From molecular mechanisms to significance in human health and disease. Antioxid. Redox Signal. 2013;18:1497&#x2013;1534. doi: 10.1089/ars.2011.4073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2011.4073</ArticleId><ArticleId IdType="pmc">PMC3603502</ArticleId><ArticleId IdType="pubmed">22938635</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson J.D., Herzenberg L.A., Vasquez K., Waltenbaugh C. Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. Proc. Natl. Acad. Sci. USA. 1998;95:3071&#x2013;3076. doi: 10.1073/pnas.95.6.3071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.6.3071</ArticleId><ArticleId IdType="pmc">PMC19696</ArticleId><ArticleId IdType="pubmed">9501217</ArticleId></ArticleIdList></Reference><Reference><Citation>Poe F.L., Corn J. N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2. Med. Hypotheses. 2020;143:109862. doi: 10.1016/j.mehy.2020.109862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.109862</ArticleId><ArticleId IdType="pmc">PMC7261085</ArticleId><ArticleId IdType="pubmed">32504923</ArticleId></ArticleIdList></Reference><Reference><Citation>De F.S., Balansky R., La M.S. Rationale for the use of N-acetylcysteine in both prevention and adjuvant therapy of COVID-19. FASEB J. 2020;34:13185&#x2013;13193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7436914</ArticleId><ArticleId IdType="pubmed">32780893</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahim H., Perl A., Smith D., Lewis T., Kon Z., Goldenberg R., Yarta K., Staniloae C., Williams M. Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine. Clin. Immunol. 2020;219:108544. doi: 10.1016/j.clim.2020.108544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108544</ArticleId><ArticleId IdType="pmc">PMC7374140</ArticleId><ArticleId IdType="pubmed">32707089</ArticleId></ArticleIdList></Reference><Reference><Citation>Assimakopoulos S.F., Aretha D., Komninos D., Dimitropoulou D., Lagadinou M., Leonidou L., Oikonomou I., Mouzaki A., Marangos M. N-acetyl-cysteine reduces the risk for mechanical ventilation and mortality in patients with COVID-19 pneumonia: A two-center retrospective cohort study. Infect. Dis. 2021;53:847&#x2013;854. doi: 10.1080/23744235.2021.1945675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1945675</ArticleId><ArticleId IdType="pubmed">34182881</ArticleId></ArticleIdList></Reference><Reference><Citation>de Alencar J.C.G., Moreira C.L., Muller A.D., Chaves C.E., Fukuhara M.A., da Silva E.A., Miyamoto M.F.S., Pinto V.B., Bueno C.G., Lazar N.F., et al. Double-blind, Randomized, Placebo-controlled Trial With N-acetylcysteine for Treatment of Severe Acute Respiratory Syndrome Caused by Coronavirus Disease 2019 (COVID-19) Clin. Infect. Dis. 2021;72:e736&#x2013;e741. doi: 10.1093/cid/ciaa1443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1443</ArticleId><ArticleId IdType="pmc">PMC7543361</ArticleId><ArticleId IdType="pubmed">32964918</ArticleId></ArticleIdList></Reference><Reference><Citation>Taher A., Lashgari M., Sedighi L., Rahimi-Bashar F., Poorolajal J., Mehrpooya M. A pilot study on intravenous N-Acetylcysteine treatment in patients with mild-to-moderate COVID19-associated acute respiratory distress syndrome. Pharmacol. Rep. 2021;73:1650&#x2013;1659. doi: 10.1007/s43440-021-00296-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43440-021-00296-2</ArticleId><ArticleId IdType="pmc">PMC8191712</ArticleId><ArticleId IdType="pubmed">34114174</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr A.C., Shaw G.M., Fowler A.A., Natarajan R. Ascorbate-dependent vasopressor synthesis: A rationale for vitamin C administration in severe sepsis and septic shock? Crit. Care. 2015;19:418. doi: 10.1186/s13054-015-1131-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-1131-2</ArticleId><ArticleId IdType="pmc">PMC4661979</ArticleId><ArticleId IdType="pubmed">26612352</ArticleId></ArticleIdList></Reference><Reference><Citation>Koekkoek W.A., van Zanten A.R. Antioxidant Vitamins and Trace Elements in Critical Illness. Nutr. Clin. Pract. 2016;31:457&#x2013;474. doi: 10.1177/0884533616653832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0884533616653832</ArticleId><ArticleId IdType="pubmed">27312081</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauling L. Ascorbic acid and the common cold. Am. J. Clin. Nutr. 1971;24:1294&#x2013;1299. doi: 10.1093/ajcn/24.11.1294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/24.11.1294</ArticleId><ArticleId IdType="pubmed">4940368</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiscano-Camon L., Ruiz-Rodriguez J.C., Ruiz-Sanmartin A., Roca O., Ferrer R. Vitamin C levels in patients with SARS-CoV-2-associated acute respiratory distress syndrome. Crit. Care. 2020;24:522. doi: 10.1186/s13054-020-03249-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03249-y</ArticleId><ArticleId IdType="pmc">PMC7447967</ArticleId><ArticleId IdType="pubmed">32847620</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao B., Ling Y., Li J., Peng Y., Huang J., Wang Y., Qu H., Gao Y., Li Y., Hu B., et al. Beneficial aspects of high dose intravenous vitamin C on patients with COVID-19 pneumonia in severe condition: A retrospective case series study. Ann. Palliat Med. 2021;10:1599&#x2013;1609. doi: 10.21037/apm-20-1387.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/apm-20-1387</ArticleId><ArticleId IdType="pubmed">33222462</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Rao X., Li Y., Zhu Y., Liu F., Guo G., Luo G., Meng Z., De B.D., Xiang H., et al. Pilot trial of high-dose vitamin C in critically ill COVID-19 patients. Ann. Intensive Care. 2021;11:5. doi: 10.1186/s13613-020-00792-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-020-00792-3</ArticleId><ArticleId IdType="pmc">PMC7794643</ArticleId><ArticleId IdType="pubmed">33420963</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumari P., Dembra S., Dembra P., Bhawna F., Gul A., Ali B., Sohail H., Kumar B., Memon M.K., Rizwan A. The Role of Vitamin C as Adjuvant Therapy in COVID-19. Cureus. 2020;12:e11779. doi: 10.7759/cureus.11779.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.11779</ArticleId><ArticleId IdType="pmc">PMC7779177</ArticleId><ArticleId IdType="pubmed">33409026</ArticleId></ArticleIdList></Reference><Reference><Citation>JamaliMoghadamSiahkali S., Zarezade B., Koolaji S., SeyedAlinaghi S., Zendehdel A., Tabarestani M., Sekhavati M.E., Abbasian L., Dehghan Manshadi S.A., Salehi M., et al. Safety and effectiveness of high-dose vitamin C in patients with COVID-19: A randomized open-label clinical trial. Eur. J. Med. Res. 2021;26:20. doi: 10.1186/s40001-021-00490-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40001-021-00490-1</ArticleId><ArticleId IdType="pmc">PMC7877333</ArticleId><ArticleId IdType="pubmed">33573699</ArticleId></ArticleIdList></Reference><Reference><Citation>Malaguarnera L. Influence of Resveratrol on the Immune Response. Nutrients. 2019;11:946. doi: 10.3390/nu11050946.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11050946</ArticleId><ArticleId IdType="pmc">PMC6566902</ArticleId><ArticleId IdType="pubmed">31035454</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonard S.S., Xia C., Jiang B.H., Stinefelt B., Klandorf H., Harris G.K., Shi X. Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem. Biophys. Res. Commun. 2003;309:1017&#x2013;1026. doi: 10.1016/j.bbrc.2003.08.105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2003.08.105</ArticleId><ArticleId IdType="pubmed">13679076</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasquereau S., Nehme Z., Haidar A.S., Daouad F., Van A.J., Wallet C., Schwartz C., Rohr O., Morot-Bizot S., Herbein G. Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro. Viruses. 2021;13:354. doi: 10.3390/v13020354.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13020354</ArticleId><ArticleId IdType="pmc">PMC7926471</ArticleId><ArticleId IdType="pubmed">33672333</ArticleId></ArticleIdList></Reference><Reference><Citation>ter Ellen B.M., Dinesh Kumar N., Bouma E.M., Troost B., van de Pol D.P.I., van der Ende-Metselaar H.H., Apperloo L., van Gosliga D., van den Berge M., Nawijn M.C., et al. Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air&#x2013;Liquid Interface Cultured Human Primary Bronchial Epithelial Cells. Viruses. 2021;13:1335. doi: 10.3390/v13071335.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13071335</ArticleId><ArticleId IdType="pmc">PMC8309965</ArticleId><ArticleId IdType="pubmed">34372541</ArticleId></ArticleIdList></Reference><Reference><Citation>de Ligt M., Hesselink M.K.C., Jorgensen J., Hoebers N., Blaak E.E., Goossens G.H. Resveratrol supplementation reduces ACE2 expression in human adipose tissue. Adipocyte. 2021;10:408&#x2013;411. doi: 10.1080/21623945.2021.1965315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21623945.2021.1965315</ArticleId><ArticleId IdType="pmc">PMC8381800</ArticleId><ArticleId IdType="pubmed">34402717</ArticleId></ArticleIdList></Reference><Reference><Citation>McCreary M.R., Schnell P.M., Rhoda D.A. Randomized Double-blind Placebo-controlled Proof-of-concept Trial of Resveratrol for Outpatient Treatment of Mild Coronavirus Disease (COVID-19) Res. Sq. 2021;rs.3:rs-861831. doi: 10.21203/rs.3.rs-861831/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-861831/v1</ArticleId><ArticleId IdType="pmc">PMC9243086</ArticleId><ArticleId IdType="pubmed">35768453</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuadrado A., Pajares M., Benito C., Jimenez-Villegas J., Escoll M., Fernandez-Gines R., Garcia Yague A.J., Lastra D., Manda G., Rojo A.I., et al. Can Activation of NRF2 Be a Strategy against COVID-19? Trends Pharmacol. Sci. 2020;41:598&#x2013;610. doi: 10.1016/j.tips.2020.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2020.07.003</ArticleId><ArticleId IdType="pmc">PMC7359808</ArticleId><ArticleId IdType="pubmed">32711925</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed S.M., Luo L., Namani A., Wang X.J., Tang X. Nrf2 signaling pathway: Pivotal roles in inflammation. Biochim Biophys Acta. Mol. Basis Dis. 2017;1863:585&#x2013;597. doi: 10.1016/j.bbadis.2016.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2016.11.005</ArticleId><ArticleId IdType="pubmed">27825853</ArticleId></ArticleIdList></Reference><Reference><Citation>Ordonez A.A., Bullen C.K., Villabona-Rueda A.F., Thompson E.A., Turner M.L., Davis S.L., Komm O., Powell J.D., D&#x2019;Alessio F.R., Yolken R.H., et al. Sulforaphane exhibits in vitro and in vivo antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses. bioRxiv. 2021 doi: 10.1101/2021.03.25.437060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.25.437060</ArticleId><ArticleId IdType="pmc">PMC8933402</ArticleId><ArticleId IdType="pubmed">35304580</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasparello J., d&#x2019;Aversa E., Papi C., Gambari L., Grigolo B., Borgatti M., Finotti A., Gambari R. Sulforaphane inhibits the expression of interleukin-6 and interleukin-8 induced in bronchial epithelial IB3-1 cells by exposure to the SARS-CoV-2 Spike protein. Phytomedicine. 2021;87:153583. doi: 10.1016/j.phymed.2021.153583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2021.153583</ArticleId><ArticleId IdType="pmc">PMC8095027</ArticleId><ArticleId IdType="pubmed">34033999</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Prete D., Taglialatela-Scafati O., Minassi A., Sirignano C., Cruz C., Bellido M.L., Munoz E., Appendino G. Electrophilic Triterpenoid Enones: A Comparative Thiol-Trapping and Bioactivity Study. J. Nat. Prod. 2017;80:2276&#x2013;2283. doi: 10.1021/acs.jnatprod.7b00271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jnatprod.7b00271</ArticleId><ArticleId IdType="pubmed">28753294</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Q., Ye F., Liang H., Liu H., Li C., Lu R., Huang B., Zhao L., Tan W., Lai L. Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease. Signal Transduct. Target Ther. 2021;6:212. doi: 10.1038/s41392-021-00628-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00628-x</ArticleId><ArticleId IdType="pmc">PMC8164054</ArticleId><ArticleId IdType="pubmed">34052830</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Missiry M.A., Fekri A., Kesar L.A., Othman A.I. Polyphenols are potential nutritional adjuvants for targeting COVID-19. Phytother. Res. 2021;35:2879&#x2013;2889. doi: 10.1002/ptr.6992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.6992</ArticleId><ArticleId IdType="pubmed">33354848</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R., Wang X., Ni L., Di X., Ma B., Niu S., Liu C., Reiter R.J. COVID-19: Melatonin as a potential adjuvant treatment. Life Sci. 2020;250:117583. doi: 10.1016/j.lfs.2020.117583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.117583</ArticleId><ArticleId IdType="pmc">PMC7102583</ArticleId><ArticleId IdType="pubmed">32217117</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessels I., Rolles B., Rink L. The Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis. Front. Immunol. 2020;11:1712. doi: 10.3389/fimmu.2020.01712.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01712</ArticleId><ArticleId IdType="pmc">PMC7365891</ArticleId><ArticleId IdType="pubmed">32754164</ArticleId></ArticleIdList></Reference><Reference><Citation>Seifirad S. Pirfenidone: A novel hypothetical treatment for COVID-19. Med. Hypotheses. 2020;144:110005. doi: 10.1016/j.mehy.2020.110005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110005</ArticleId><ArticleId IdType="pmc">PMC7297676</ArticleId><ArticleId IdType="pubmed">32575019</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Saad R., Taylor E.W., Rayman M.P. Selenium and selenoproteins in viral infection with potential relevance to COVID-19. Redox Biol. 2020;37:101715. doi: 10.1016/j.redox.2020.101715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2020.101715</ArticleId><ArticleId IdType="pmc">PMC7481318</ArticleId><ArticleId IdType="pubmed">32992282</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>